These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 25639729)
1. Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth. Chen S; Feng J; Bao Q; Li A; Zhang B; Shen Y; Zhao Y; Guo Q; Jing J; Lin S; Zong Z J Bone Miner Res; 2015 Jul; 30(7):1184-94. PubMed ID: 25639729 [TBL] [Abstract][Full Text] [Related]
2. Osteocytes but not osteoblasts directly build mineralized bone structures. Wang K; Ren Y; Lin S; Jing Y; Ma C; Wang J; Yuan XB; Han X; Zhao H; Wang Z; Zheng M; Xiao Y; Chen L; Olsen BR; Feng JQ Int J Biol Sci; 2021; 17(10):2430-2448. PubMed ID: 34326685 [TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength. Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532 [TBL] [Abstract][Full Text] [Related]
4. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone. Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937 [TBL] [Abstract][Full Text] [Related]
5. Constitutive β-catenin activation in osteoblasts impairs terminal osteoblast differentiation and bone quality. Bao Q; Chen S; Qin H; Feng J; Liu H; Liu D; Li A; Shen Y; Zhong X; Li J; Zong Z Exp Cell Res; 2017 Jan; 350(1):123-131. PubMed ID: 27865936 [TBL] [Abstract][Full Text] [Related]
6. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086 [TBL] [Abstract][Full Text] [Related]
7. Aberrant activation of Wnt signaling pathway altered osteocyte mineralization. Zhou Y; Lin J; Shao J; Zuo Q; Wang S; Wolff A; Nguyen DT; Rintoul L; Du Z; Gu Y; Peng YY; Ramshaw JAM; Long X; Xiao Y Bone; 2019 Oct; 127():324-333. PubMed ID: 31260814 [TBL] [Abstract][Full Text] [Related]
8. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. Hens JR; Wilson KM; Dann P; Chen X; Horowitz MC; Wysolmerski JJ J Bone Miner Res; 2005 Jul; 20(7):1103-13. PubMed ID: 15940363 [TBL] [Abstract][Full Text] [Related]
9. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes. McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783 [TBL] [Abstract][Full Text] [Related]
10. Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Lau KH; Baylink DJ; Zhou XD; Rodriguez D; Bonewald LF; Li Z; Ruffoni D; Müller R; Kesavan C; Sheng MH Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E271-81. PubMed ID: 23715728 [TBL] [Abstract][Full Text] [Related]
11. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation. Kang KS; Hong JM; Robling AG Bone; 2016 Jul; 88():138-145. PubMed ID: 27143110 [TBL] [Abstract][Full Text] [Related]
12. Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling. Tang Y; Yang P; Jin M; Huang S; Chen H; Chen L; Yang J; Su N Bone; 2023 Sep; 174():116817. PubMed ID: 37268269 [TBL] [Abstract][Full Text] [Related]
13. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice. Li J; Bao Q; Chen S; Liu H; Feng J; Qin H; Li A; Liu D; Shen Y; Zhao Y; Zong Z J Orthop Res; 2017 Apr; 35(4):812-819. PubMed ID: 27306622 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling. Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588 [TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization. Li F; Song N; Tombran-Tink J; Niyibizi C J Cell Physiol; 2015 Jun; 230(6):1243-9. PubMed ID: 25363869 [TBL] [Abstract][Full Text] [Related]
17. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Rossini M; Gatti D; Adami S Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710 [TBL] [Abstract][Full Text] [Related]
18. The Dmp1-SOST Transgene Interacts With and Downregulates the Dmp1-Cre Transgene and the Rosa(Notch) Allele. Zanotti S; Canalis E J Cell Biochem; 2016 May; 117(5):1222-32. PubMed ID: 26456319 [TBL] [Abstract][Full Text] [Related]
19. Mef2c deletion in osteocytes results in increased bone mass. Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow fibrosis with fibrocytic and immunoregulatory responses induced by β-catenin activation in osteoprogenitors. Yu J; Cao J; Li H; Liu P; Xu S; Zhou R; Yao Z; Guo X Bone; 2016 Mar; 84():38-46. PubMed ID: 26688275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]